Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
What is the best treatment of drug-resistant trigeminal neuralgia in patients affected by multiple sclerosis? A literature analysis of surgical procedures.
[Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : A systematic review.]
A method for histopathological study of the multifocal nature of spinal cord lesions in murine experimental autoimmune encephalomyelitis.
Methods and measures: what's new for MS?
Occupational Exposure and Risk of Central Nervous System Demyelination.
A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: it's time!
Clinical application of susceptibility weighted imaging: exploring from routine service.
TH17 cell differentiation is regulated by the circadian clock.
Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients.
Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses.
7T MRI in natalizumab-associated PML and ongoing MS disease activity: A case study.
Does the patient know best? Quality of life assessment in multiple sclerosis trials.
The socioeconomic consequences of optic neuritis with and without multiple sclerosis: a controlled national study.
Setting new standards in multiple sclerosis care and research.
Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica.
Exosomes as a potential novel therapeutic tools against neurodegenerative diseases.
Personality characteristics in MS patients: The role of avoidant personality.
Magnetic resonance imaging induced acute midfacial pain - incidental finding of a dislocated dental bur.
Effect of IL-17A blockade with secukinumab in autoimmune diseases.
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.
Self-tolerance in multiple sclerosis.
Editorial: new avenues of research on multiple sclerosis from the perspective of chronic cerebrospinal venous insufficiency paradigm.
The relationship between upper leg muscle strength and walking capacity in persons with multiple sclerosis.
Stress, Depression and Antidepressant Treatment Options in Patients Suffering from Multiple Sclerosis.
Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients.
Pages
« first
‹ previous
…
234
235
236
237
238
239
240
241
242
…
next ›
last »